Global Neuroscience Antibodies & Assays Market Report 2024

Neuroscience Antibodies & Assays Global Market Report 2024 – By Product (Consumables, Instruments ), By Technology (Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies ), By Application (In Vitro Diagnostics, Research, Drug Discovery ), By End User (Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : 200 | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Neuroscience Antibodies & Assays Market

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Neuroscience Antibodies & Assays Market Definition And Segments

The neuroscience antibodies & assays are used to study the development, systems, structure and function, disorders, and degeneration of the nervous system. Neuroscience is the study of the nervous system, its working, and diseases related to the nervous system. Antibodies and assays is a medical test that is based on principles of interaction between antigenic epitopes and antibodies, and this test is useful in neuroscience and the study of neurological disorders.

The main types of neuroscience antibodies & assays market products are consumables, and instruments. Consumables are used in many neurological studies and research experiments. Consumable includes assay kits, reagents, and antibodies that enable quantitative and real-time live-cell analysis. The technologies used are molecular diagnostics, clinical chemistry, immunoassays or immunochemistry, and other technologies. The various applications are in vitro diagnostics, research, and drug discovery. The various end users are hospitals and diagnostics centers, academic and research institutes, pharmaceutical and biotechnology companies.

The neuroscience antibodies & assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies

3) By Application: In Vitro Diagnostics, Research, Drug Discovery

4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies

The neuroscience antibodies & assays market size has grown rapidly in recent years. It will grow from $4.1 billion in 2023 to $4.63 billion in 2024 at a compound annual growth rate (CAGR) of 13.0%. The growth in the historic period can be attributed to research funding, drug discovery and development, neurodegenerative diseases, government initiatives, personalized medicine.

The neuroscience antibodies & assays market size is expected to see rapid growth in the next few years. It will grow to $7.68 billion in 2028 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to collaborations, telemedicine in neurology, education and training, biomarker-driven therapies, neuroimmunology focus . Major trends in the forecast period include microrna and non-coding rna assays, digital pathology, advanced imaging-compatible assays, single-cell analysis, 3d organoid models.

Surge In Neurological Illnesses Spurs Remarkable Growth In The Neuroscience Antibodies & Assays Market

The increase in incidents of neurological illnesses across the globe are expected to propel the growth of the neuroscience antibodies & assays market going forward. Neurological illnesses are disorders and affecting the nervous system, and examples of neurological disorders include epilepsy, Alzheimer’s disease, dementia, and so on. The rise in the number of neurological illnesses requires more research and development activities for the treatment of these diseases. Antibodies and assays are used in research and development activities to study development, systems, structure and function, and disorders and degeneration of the nervous system. Thus, the neuroscience antibodies & assays market grows with the increase in incidents of neurological illnesses. For instance, According to the World Health Organization, a Switzerland-based health promotion agency 55 million people live with dementia globally, and there are nearly 10 million new cases every year as per 2021 data. According to Alzheimer's Association a US based Non-profit association, 6.5 million people in the US have Alzheimer's disease as per 2022 data. As a result, the increased incidence of neurological illnesses across the world is driving the neuroscience antibodies and assays market forward.

Surging Healthcare Sector Fueling Growth In Neuroscience Antibodies & Assays Market

The increasing healthcare sector is expected to drive the growth of neuroscience antibodies & assays market. The healthcare sector refers to the collection of organizations, institutions, professionals, and resources dedicated to providing medical services, healthcare products, and support for maintaining or improving people's health. Neuroscience antibodies and assays are extensively used in the healthcare sector for a variety of purposes due to their ability to detect and measure specific proteins, biomarkers, and molecular processes in the nervous system. For instance, according to BlackRock Inc., a US-based investment management corporation, in 2021, the global healthcare sector highlighted growth and returned +19.8%. Therefore the increasing healthcare sector is expected to propel the growth of neuroscience antibodies & assays market going forward.

Major companies operating in the neuroscience antibodies & assays market include Abcam PLC, BioLegend Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Merck KGaA, Rockland Immunochemicals Inc., GenScript Biotech Corporation, Santa Cruz Biotechnology Inc., Wak-Chemie Medical GmbH, Epitope Diagnostics Inc., Agilent Technologies, Bio-Techne Corporation, Creative Diagnostics, Enzo Life Sciences Inc., Jackson ImmunoResearch Laboratories Inc., Novus Biologicals LLC, OriGene Technologies Inc., Proteintech Group Inc., R&D Systems Inc., RayBiotech Inc., StressMarq Biosciences Inc., Synaptic Systems GmbH, Tocris Bioscience, Alomone Labs Ltd., AnaSpec Inc., Antibodies.com, Antibody Solutions, Arbor Assays, Uscn Life Science Inc., Zymo Research Corp., AAT Bioquest Inc., Abbexa Ltd., ACROBiosystems Inc., Active Motif Inc., AdipoGen Life Sciences, Advanced Targeting Systems Inc., AgriSera AB

Neuronexus Summa Framework Sets New Technological Standard In Antibodies And Assays Market

Technological advancements are a key trend gaining popularity in the neuroscience antibodies and assays market. Major companies operating in the market are introducing new technologies such as NeuroNexus Summa Framework technology to sustain their position in the market. For instance, in February 2022 NeuroNexus Technologies, a US-based innovative neural interface products and technologies provider announced the launch of NeuroNexus Summa Framework. The solution was designed for both experienced electrophysiologists and life science researchers who are looking to easily incorporate electrical signal read-outs from biological cells and tissues into their research workflow.

Product Innovation To Support Research And Diagnostics In Neuroscience

Major companies operating in the neuroscience antibodies and assays market are developing innovative products to meet the growing demand. Product innovation includes a growing emphasis on developing novel and advanced products to support research and diagnostics in neuroscience. For instance, in July 2022, Labcorp, a US-based healthcare company, announced the launch of the Neurofilament Light Chain (NFL) blood test. The test enables physicians to detect and confirm indicators of neurodegenerative diseases, enhancing their ability to offer patients a more streamlined and improved route to diagnosis and treatment. Moreover, this Neurofilament Light Chain (NFL) blood test has the potential to improve the diagnosis, treatment, and management of neurological disorders.

Fujirebio Expands Global Reach In Neurodegenerative Disease Diagnostics With Adx Neurosciences Acquisition

In June 2022, Fujirebio, a Japanese multinational biotechnology company, acquired ADx NeuroSciences for an undisclosed amount. With this acquisition, Fujirebio will be able to provide neurodegenerative disease diagnostic solutions at the global level. ADx Neurosciences is a Belgium-based developer of neurodegenerative biomarkers and specialized in developing tailor-made antibodies and assays for pharma and in vitro diagnostics companies.

North America was the largest region in the neuroscience antibodies & assays market in 2023. The regions covered in the neuroscience antibodies & assays market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neuroscience antibodies & assays market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The neuroscience antibodies & assays market consists of sales of antibodies and assay kits and reagents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The neuroscience antibodies & assays market research report is one of a series of new reports from The Business Research Company that provides neuroscience antibodies & assays market statistics, including neuroscience antibodies & assays industry global market size, regional shares, competitors with an neuroscience antibodies & assays market share, detailed neuroscience antibodies & assays market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience antibodies & assays industry. This neuroscience antibodies & assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Neuroscience Antibodies & Assays Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $4.63 billion
Revenue Forecast In 2033 $7.68 billion
Growth Rate CAGR of 13.5% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Consumables, Instruments
2) By Technology: Molecular Diagnostics, Clinical Chemistry, Immunoassays Or Immunochemistry, Others Technologies
3) By Application: In Vitro Diagnostics, Research, Drug Discovery
4) By End User: Hospitals And Diagnostics Centers, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Abcam plc; BioLegend Inc.; Bio-Rad Laboratories Inc.; Cell Signaling Technology Inc.; F. Hoffmann-La Roche AG; Thermo Fisher Scientific; Merck KGaA; Rockland Immunochemicals Inc.; GenScript Biotech Corporation; Santa Cruz Biotechnology Inc.; Wak-Chemie Medical GmbH; Epitope Diagnostics Inc.; Agilent Technologies; Bio-Techne Corporation; Creative Diagnostics; Enzo Life Sciences Inc.; Jackson ImmunoResearch Laboratories Inc.; Novus Biologicals LLC; OriGene Technologies Inc.; Proteintech Group Inc.; R&D Systems Inc.; RayBiotech Inc.; StressMarq Biosciences Inc.; Synaptic Systems GmbH; Tocris Bioscience; Alomone Labs Ltd.; AnaSpec Inc.; Antibodies.com; Antibody Solutions; Arbor Assays; Uscn Life Science Inc.; Zymo Research Corp.; AAT Bioquest Inc.; Abbexa Ltd.; ACROBiosystems Inc.; Active Motif Inc.; AdipoGen Life Sciences; Advanced Targeting Systems Inc.; AgriSera AB
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Neuroscience Antibodies & Assays Market Characteristics

    3. Neuroscience Antibodies & Assays Market Trends And Strategies

    4. Neuroscience Antibodies & Assays Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Neuroscience Antibodies & Assays Market Size and Growth

    5.1. Global Neuroscience Antibodies & Assays Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Neuroscience Antibodies & Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Neuroscience Antibodies & Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Neuroscience Antibodies & Assays Market Segmentation

    6.1. Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Consumables

    Instruments  

    6.2. Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Molecular Diagnostics

    Clinical Chemistry

    Immunoassays Or Immunochemistry

    Others Technologies  

    6.3. Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    In Vitro Diagnostics

    Research

    Drug Discovery  

    6.4. Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Diagnostics Centers

    Academic And Research Institutes

    Pharmaceutical And Biotechnology Companies

    7. Neuroscience Antibodies & Assays Market Regional And Country Analysis

    7.1. Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Neuroscience Antibodies & Assays Market  

    8.1. Asia-Pacific Neuroscience Antibodies & Assays Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Neuroscience Antibodies & Assays Market  

    9.1. China Neuroscience Antibodies & Assays Market Overview  

    9.2. China Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Neuroscience Antibodies & Assays Market  

    10.1. India Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Neuroscience Antibodies & Assays Market  

    11.1. Japan Neuroscience Antibodies & Assays Market Overview  

    11.2. Japan Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Neuroscience Antibodies & Assays Market  

    12.1. Australia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Neuroscience Antibodies & Assays Market  

    13.1. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Neuroscience Antibodies & Assays Market  

    14.1. South Korea Neuroscience Antibodies & Assays Market Overview  

    14.2. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Neuroscience Antibodies & Assays Market  

    15.1. Western Europe Neuroscience Antibodies & Assays Market Overview

    15.2. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Neuroscience Antibodies & Assays Market  

    16.1. UK Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Neuroscience Antibodies & Assays Market  

    17.1. Germany Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Neuroscience Antibodies & Assays Market  

    18.5. France Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Neuroscience Antibodies & Assays Market  

    19.9. Italy Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Neuroscience Antibodies & Assays Market  

    20.13. Spain Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Neuroscience Antibodies & Assays Market  

    21.1. Eastern Europe Neuroscience Antibodies & Assays Market Overview

    21.2. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Neuroscience Antibodies & Assays Market  

    22.1. Russia Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Neuroscience Antibodies & Assays Market  

    23.1. North America Neuroscience Antibodies & Assays Market Overview

    23.2. North America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Neuroscience Antibodies & Assays Market  

    24.1. USA Neuroscience Antibodies & Assays Market Overview

    24.2. USA Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Neuroscience Antibodies & Assays Market  

    25.1. Canada Neuroscience Antibodies & Assays Market Overview

    25.2. Canada Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Neuroscience Antibodies & Assays Market  

    26.1. South America Neuroscience Antibodies & Assays Market Overview

    26.2. South America Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Neuroscience Antibodies & Assays Market  

    27.1. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Neuroscience Antibodies & Assays Market  

    28.1. Middle East Neuroscience Antibodies & Assays Market Overview

    28.2. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Neuroscience Antibodies & Assays Market  

    29.1. Africa Neuroscience Antibodies & Assays Market Overview

    29.2. Africa Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Neuroscience Antibodies & Assays Market Competitive Landscape And Company Profiles

    30.1. Neuroscience Antibodies & Assays Market Competitive Landscape

    30.2. Neuroscience Antibodies & Assays Market Company Profiles

    30.2.1. Abcam plc

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. BioLegend Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Bio-Rad Laboratories Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Cell Signaling Technology Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. F. Hoffmann-La Roche AG

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Neuroscience Antibodies & Assays Market Competitive Benchmarking

    32. Global Neuroscience Antibodies & Assays Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Neuroscience Antibodies & Assays Market

    34. Neuroscience Antibodies & Assays Market Future Outlook and Potential Analysis

    34.1 Neuroscience Antibodies & Assays Market In 2028 - Countries Offering Most New Opportunities

    34.2 Neuroscience Antibodies & Assays Market In 2028 - Segments Offering Most New Opportunities

    34.3 Neuroscience Antibodies & Assays Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Abcam plc Financial Performance
  • Table 76: BioLegend Inc. Financial Performance
  • Table 77: Bio-Rad Laboratories Inc. Financial Performance
  • Table 78: Cell Signaling Technology Inc. Financial Performance
  • Table 79: F. Hoffmann-La Roche AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Neuroscience Antibodies & Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Neuroscience Antibodies & Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Neuroscience Antibodies & Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Neuroscience Antibodies & Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Neuroscience Antibodies & Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Abcam plc Financial Performance
  • Figure 76: BioLegend Inc. Financial Performance
  • Figure 77: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 78: Cell Signaling Technology Inc. Financial Performance
  • Figure 79: F. Hoffmann-La Roche AG Financial Performance
Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies
Read More
Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company
Read More
What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?
Read More
How Will The Laryngoscope Market Grow In 2022?
Read More
The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the narcotics scanner market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft doors market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the aircraft landing gear market research report 2022 with industry size, share, segments and market growth
Read More
Neurology Devices Global Market Report 2024 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Device), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-203
View Report
Neurodegenerative Disorder Therapeutics Global Market Report 2024 – By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types), By Drug Type (N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types), By Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurophysiology Devices And Equipment Global Market Report 2024 – By Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked potential (EP)), By Modality (Standalone, Portable), By End Users (Hospitals, Ambulatory Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Monoclonal Antibodies (MAs) Global Market Report 2024 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurostimulation Devices Global Market Report 2024 – By Product (Implantable Devices, External Devices), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), By End User (Hospitals, Rehabilitation Centers, Medical Clinic) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neuroprosthetics Global Market Report 2024 – By Type (Motor Neuroprosthetics, Auditory Neuroprosthetics/ Cochlear implants, Visual Neuroprosthetics/ Retinal implants, Cognitive Neuroprosthetics ), By Technique (Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Transcranial Magnetic Stimulation ), By Application (Motor Neuron Disorders, Physiological Disorders, Cognitive Disorders ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Neurology Devices Global Market Report 2024 – By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Device), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-203
View Report
Interventional Neurology Devices And Equipment Global Market Report 2024 – By Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices), Aneurysm Coiling & Embolization Devices By Type (Embolic coils, Flow diversion devices, Liquid embolic devices), Angioplasty Devices by Type (Carotid artery stents, Embolic protection systems), Support Devices By Type, Micro guide wires, Micro catheters), Neurothrombectomy Devices By Type (CLOT retrieval devices, Suction and aspiration devices, Snare), By End-User (Hospitals, Neurology clinics, Ambulatory care centers and others) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the nematicidesmarket?

The nematicides market consists of sales of nematicides by entities (organizations, sole traders, and partnerships) that are chemically derived compounds that kill or hurt nematodes. Nematicides have generally been broad-spectrum toxicants with high volatility or other qualities that facilitate soil movement. These are used to kill parasitic worms including roundworms and threadworms. For further insights on the nematicides market, request a sample here

How will the nematicides market drivers and restraints affect the nematicides market dynamics? What forces will shape the nematicides industry going forward?

The nematicides market major growth driver - surging demand for high-value crops fuels growth in the nematicides market. For further insights on the nematicides market, request a sample here

What is the forecast market size or the forecast market value of the nematicides market ?

The nematicides market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to crop protection, agricultural productivity, soil health, global food demand, regulatory support. The nematicides market size is expected to see strong growth in the next few years. It will grow to $2.31 billion in 2028 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to organic farming, precision agriculture, climate change impacts, integrated pest management (ipm), alternative pest control methods. Major trends in the forecast period include sustainable agriculture certification, biological nematicides, research and innovation, data-driven decision-making, chemical nematicides. For further insights on the nematicides market, request a sample here

How is the nematicides market segmented?

The nematicides market is segmented
1) By Type: Fumigants, Bio Nematicides, Organophosphates, Carbamates, Other Types
2) By Form: Granular Or Powder, Liquid
3) By Crop Type: Fruits and Vegetables, Oilseeds, Cereals and Grains, Other Crop Types
4) By Application: Fumigation, Soil Dressing, Drenching, Seed Treatment, Other ApplicationsFor further insights on the nematicides market, request a sample here

Which region has the largest share of the nematicides market? What are the other regions covered in the report?

North America was the largest region in the nematicides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nematicides market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on the nematicides market, request a sample here.

Who are the major players in the nematicides market?

Major companies operating in the nematicides market include Adama Agricultural Solutions Ltd., BASF SE, Bayer Crop Science AG, Certis L.L.C, Corteva Inc., Crop IQ Technology Group, Horizon Group, Isagro Group, Marrone Bio Innovations Inc., Nufarm Limited, Syngenta AG, Dow Inc., UPL Limited, Valent L.L.C, Agri Life, BioWorks Inc., Brandt Consolidated Inc., Chr. Hansen Holding A/S, American Vanguard Corporation, FMC Corporation, Monsanto Company, Sumitomo Chemical Co. Ltd., Camson Bio Technologies Limited, Terramera Inc., Gowan Company LLC, AgBiome Inc., Novozymes A/S, Verdesian Life Sciences LLC, NemaLife Sciences LLC, AgroLiquid LLC, BioSafe Systems LLC For further insights on the nematicides market, request a sample here.

What are the key trends in the nematicides market?

Major trend in the nematicides market - technological advancements to sustain market position. For further insights on the nematicides market, request a sample here.

What are the major opportunities in the nematicides market? What are the strategies for the nematicides market?

For detailed insights on the major opportunities and strategies in the nematicides market, request a sample here.

How does the nematicides market relate to the overall economy and other similar markets?

For detailed insights on nematicides market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the nematicides industry?

For detailed insights on the mergers and acquisitions in the nematicides industry, request a sample here.

What are the key dynamics influencing the nematicides market growth? SWOT analysis of the nematicides market.

For detailed insights on the key dynamics influencing the nematicides market growth and SWOT analysis of the nematicides industry, request a sample here.